Log in to save to my catalogue

Palmitoylethanolamide Protects Against the Amyloid- beta 25-35-Induced Learning and Memory Impairmen...

Palmitoylethanolamide Protects Against the Amyloid- beta 25-35-Induced Learning and Memory Impairmen...

https://devfeature-collection.sl.nsw.gov.au/record/TN_cdi_proquest_miscellaneous_1017976202

Palmitoylethanolamide Protects Against the Amyloid- beta 25-35-Induced Learning and Memory Impairment in Mice, an Experimental Model of Alzheimer Disease

About this item

Full title

Palmitoylethanolamide Protects Against the Amyloid- beta 25-35-Induced Learning and Memory Impairment in Mice, an Experimental Model of Alzheimer Disease

Journal title

Neuropsychopharmacology (New York, N.Y.), 2012-06, Vol.37 (7), p.1784-1792

Language

English

Formats

More information

Scope and Contents

Contents

Alzheimer disease (AD) is the most common form of neurodegenerative dementia. Amyloid- beta deposition, neurofibrillary tangle formation, and neuro-inflammation are the major pathogenic mechanisms that in concert lead to memory dysfunction and decline of cognition. Palmitoylethanolamide (PEA) is the naturally occurring lipid amide between palmitic...

Alternative Titles

Full title

Palmitoylethanolamide Protects Against the Amyloid- beta 25-35-Induced Learning and Memory Impairment in Mice, an Experimental Model of Alzheimer Disease

Identifiers

Primary Identifiers

Record Identifier

TN_cdi_proquest_miscellaneous_1017976202

Permalink

https://devfeature-collection.sl.nsw.gov.au/record/TN_cdi_proquest_miscellaneous_1017976202

Other Identifiers

ISSN

0893-133X

DOI

10.1038/npp.2012.25

How to access this item